555

BIOVENTIX PLC

No trades
See on Supercharts

51B fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

51B does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company